Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.

Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC Jr, Spooner CE, Chen H, Ballard J, James JA, Farris AD.

Clin Vaccine Immunol. 2017 Nov 6;24(11). pii: e00165-17. doi: 10.1128/CVI.00165-17. Print 2017 Nov.

2.

Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.

Dumas EK, Garman L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Choudhari S, Picking WD, James JA, Farris AD.

Vaccine. 2017 Jun 8;35(26):3416-3422. doi: 10.1016/j.vaccine.2017.05.006. Epub 2017 May 11.

3.

Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profiles.

Ellsworth DL, Costantino NS, Blackburn HL, Engler RJ, Kashani M, Vernalis MN.

Obes Sci Pract. 2016 Sep;2(3):282-292. Epub 2016 Jul 25.

4.

International Consensus (ICON): allergic reactions to vaccines.

Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Rosenwasser LJ.

World Allergy Organ J. 2016 Sep 16;9(1):32. doi: 10.1186/s40413-016-0120-5. eCollection 2016.

6.

Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination.

Garman L, Smith K, Muns EE, Velte CA, Spooner CE, Munroe ME, Farris AD, Nelson MR, Engler RJ, James JA.

Clin Vaccine Immunol. 2016 Aug 5;23(8):664-71. doi: 10.1128/CVI.00092-16. Print 2016 Aug.

7.

Early Empowerment Strategies Boost Self-Efficacy to Improve Cardiovascular Health Behaviors.

Kashani M, Eliasson AH, Walizer EM, Fuller CE, Engler RJ, Villines TC, Vernalis MN.

Glob J Health Sci. 2016 Sep 1;8(9):55119. doi: 10.5539/gjhs.v8n9p322.

8.

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification.

Ellsworth DL, Mamula KA, Blackburn HL, McDyer FA, Jellema GL, van Laar R, Costantino NS, Engler RJ, Vernalis MN.

Obesity (Silver Spring). 2015 Jun;23(6):1312-9. doi: 10.1002/oby.21079. Epub 2015 May 9.

9.

A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination.

Engler RJ, Nelson MR, Collins LC Jr, Spooner C, Hemann BA, Gibbs BT, Atwood JE, Howard RS, Chang AS, Cruser DL, Gates DG, Vernalis MN, Lengkeek MS, McClenathan BM, Jaffe AS, Cooper LT, Black S, Carlson C, Wilson C, Davis RL.

PLoS One. 2015 Mar 20;10(3):e0118283. doi: 10.1371/journal.pone.0118283. eCollection 2015.

10.

Humoral responses to independent vaccinations are correlated in healthy boosted adults.

Garman L, Vineyard AJ, Crowe SR, Harley JB, Spooner CE, Collins LC, Nelson MR, Engler RJ, James JA.

Vaccine. 2014 Sep 29;32(43):5624-31. doi: 10.1016/j.vaccine.2014.08.005. Epub 2014 Aug 17.

11.

Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity.

Garman L, Smith K, Farris AD, Nelson MR, Engler RJ, James JA.

Toxins (Basel). 2014 Aug 13;6(8):2424-31. doi: 10.3390/toxins6082424.

12.

Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.

McNeil MM, Cano M, R Miller E, Petersen BW, Engler RJ, Bryant-Genevier MG.

Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18.

13.

Military healthcare providers reporting of adverse events following immunizations to the vaccine adverse event reporting system.

Li R, McNeil MM, Pickering S, Pemberton MR, Duran LL, Collins LC, Nelson MR, Engler RJ.

Mil Med. 2014 Apr;179(4):435-41. doi: 10.7205/MILMED-D-13-00391.

14.

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.

Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM.

Vaccine. 2013 Dec 9;31(51):6107-12. doi: 10.1016/j.vaccine.2013.09.066. Epub 2013 Oct 8.

PMID:
24120547
15.

Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).

Tack DM, Karem KL, Montgomery JR, Collins L, Bryant-Genevier MG, Tiernan R, Cano M, Lewis P, Engler RJ, Damon IK, Reynolds MG.

Hum Vaccin Immunother. 2013 Jul;9(7):1489-96. doi: 10.4161/hv.24319. Epub 2013 Apr 9. Review.

PMID:
23571177
16.

A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?

McNeil MM, Arana J, Stewart B, Hartshorn M, Hrncir D, Wang H, Lamias M, Locke M, Stamper J, Tokars JI, Engler RJ.

Vaccine. 2012 Mar 23;30(14):2421-6. doi: 10.1016/j.vaccine.2012.01.072. Epub 2012 Feb 3.

PMID:
22310205
17.

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.

Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.

PMID:
21502239
18.

Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.

Crowe SR, Garman L, Engler RJ, Farris AD, Ballard JD, Harley JB, James JA.

Vaccine. 2011 May 9;29(20):3670-8. doi: 10.1016/j.vaccine.2011.03.011. Epub 2011 Mar 21.

19.

Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Crowe SR, Ash LL, Engler RJ, Ballard JD, Harley JB, Farris AD, James JA.

J Infect Dis. 2010 Jul 15;202(2):251-60. doi: 10.1086/653495.

20.

Complementary and alternative medicine education: Need for expanded educational resources for American Academy of Allergy, Asthma & Immunology members.

Engler RJ, Silvers WS, Bielory L.

J Allergy Clin Immunol. 2009 Feb;123(2):511-2. doi: 10.1016/j.jaci.2008.11.020. No abstract available.

PMID:
19203668
21.

Complementary and alternative medicine for the allergist-immunologist: where do I start?

Engler RJ, With CM, Gregory PJ, Jellin JM.

J Allergy Clin Immunol. 2009 Feb;123(2):309-16. doi: 10.1016/j.jaci.2009.01.001. Review.

22.

Severe postvaccinia encephalitis with acute disseminated encephalomyelitis: recovery with early intravenous immunoglobulin, high-dose steroids, and vaccinia immunoglobulin.

Van Dam CN, Syed S, Eron JJ, Ostrander M, Engler RJ, Damon I, Montgomery JR, Tong S, Adimora AA, Kahn KA, Ruone S, Anderson L, Weber DJ.

Clin Infect Dis. 2009 Feb 15;48(4):e47-9. doi: 10.1086/596553.

PMID:
19133803
23.

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ; Walter Reed Health Care System Influenza Vaccine Consortium.

Arch Intern Med. 2008 Dec 8;168(22):2405-14. doi: 10.1001/archinternmed.2008.513.

PMID:
19064822
24.

An algorithm for treatment of patients with hypersensitivity reactions after vaccines.

Wood RA, Berger M, Dreskin SC, Setse R, Engler RJ, Dekker CL, Halsey NA; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network.

Pediatrics. 2008 Sep;122(3):e771-7. doi: 10.1542/peds.2008-1002.

PMID:
18762513
25.

Induction and measurement of in vivo antibody responses.

Engler RJ, Kurman CC, Nelson DL.

Curr Protoc Immunol. 2001 May;Chapter 7:Unit 7.16. doi: 10.1002/0471142735.im07016s00.

PMID:
18432830
26.

Optic neuritis and vaccination investigation: failure to consider significant sex differences and multiple vaccine combinations.

Engler RJ, Klote M, Nelson MR.

Arch Neurol. 2007 Nov;64(11):1673-4; discussion 1674-5. No abstract available.

PMID:
17998455
27.

Response to sex differences in autoimmune disease.

Klote MM, Engler RJ.

Lupus. 2007;16(6):457. No abstract available.

PMID:
17664240
28.

Vaccinia DNA in blood after smallpox vaccination.

Klote MM, Engler RJ, Martin BL, Cummings JF, Wortmann GW, Ludwig GV.

JAMA. 2006 Sep 20;296(11):1350-1; author reply 1351-2. No abstract available.

PMID:
16985223
29.

Immunization to protect the US Armed Forces: heritage, current practice, and prospects.

Grabenstein JD, Pittman PR, Greenwood JT, Engler RJ.

Epidemiol Rev. 2006;28:3-26. Epub 2006 Jun 8. Review.

PMID:
16763072
30.

Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination.

Klote MM, Ludwig GV, Ulrich MP, Black LA, Hack DC, Engler RJ, Martin BL.

Ann Allergy Asthma Immunol. 2005 Jun;94(6):682-5.

PMID:
15984602
31.

Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues.

Song TT, Nelson MR, Chang JH, Engler RJ, Chowdhury BA.

Ann Allergy Asthma Immunol. 2005 May;94(5):539-42.

PMID:
15945556
32.

Autoimmune urticaria response to high-dose intravenous immunoglobulin.

Klote MM, Nelson MR, Engler RJ.

Ann Allergy Asthma Immunol. 2005 Feb;94(2):307-8. No abstract available.

PMID:
15765750
33.

Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites.

Peng Z, Beckett AN, Engler RJ, Hoffman DR, Ott NL, Simons FE.

J Allergy Clin Immunol. 2004 Nov;114(5):1189-94. Erratum in: J Allergy Clin Immunol. 2005 Feb;115(2):376.

PMID:
15536430
34.

Myopericarditis following smallpox vaccination.

Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJ, Collins LC, Ludwig SL, Riddle JR, Grabenstein JD, Tornberg DN.

Am J Epidemiol. 2004 Oct 1;160(7):642-51.

PMID:
15383408
35.

Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination.

Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, Boyd SY, Murphy JG, Swerdlow DL, Collins LC, Riddle JR, Tornberg DN, Grabenstein JD, Engler RJ; Department of Defense Smallpox Vaccination Clinical Evaluation Team.

J Am Coll Cardiol. 2004 Jul 7;44(1):201-5. Review.

PMID:
15234435
36.

Using a structured medical note for determining the safety profile of anthrax vaccine for US soldiers in Korea.

Hoffman K, Costello C, Menich M, Grabenstein JD, Engler RJ.

Vaccine. 2003 Oct 1;21(27-30):4399-409.

PMID:
14505923
37.

Adverse reactions to vaccines.

Martin BL, Nelson MR, Hershey JN, Engler RJ.

Clin Rev Allergy Immunol. 2003 Jun;24(3):263-76. Review.

PMID:
12721397
38.

Smallpox vaccination: Risk considerations for patients with atopic dermatitis.

Engler RJ, Kenner J, Leung DY.

J Allergy Clin Immunol. 2002 Sep;110(3):357-65.

PMID:
12209080
39.

Deleterious effects of electron beam radiation on allergen extracts.

Katial RK, Grier TJ, Hazelhurst DM, Hershey J, Engler RJ.

J Allergy Clin Immunol. 2002 Aug;110(2):215-9.

PMID:
12170260
40.

Mosquito bite pathogenesis in necrotic skin reactors.

Engler RJ.

Curr Opin Allergy Clin Immunol. 2001 Aug;1(4):349-52. Review.

PMID:
11964711
41.

Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.

Katial RK, Hershey J, Purohit-Seth T, Belisle JT, Brennan PJ, Spencer JS, Engler RJ.

Clin Diagn Lab Immunol. 2001 Mar;8(2):339-45.

42.

Alternative and complementary medicine: a source of improved therapies for asthma? A challenge for redefining the specialty?

Engler RJ.

J Allergy Clin Immunol. 2000 Oct;106(4):627-9. No abstract available.

PMID:
11031331
43.

Varicella immunity: persistent serologic non-response to immunization.

Katial RK, Ratto-Kim S, Sitz KV, Moriarity R, Engler RJ.

Ann Allergy Asthma Immunol. 1999 May;82(5):431-4.

PMID:
10353572
44.

Probenecid hypersensitivity in AIDS: a case report.

Myers KW, Katial RK, Engler RJ.

Ann Allergy Asthma Immunol. 1998 May;80(5):416-8.

PMID:
9609613
46.

Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI)

Shearer WT, Buckley RH, Engler RJ, Finn AF Jr, Fleisher TA, Freeman TM, Herrod HG 3rd, Levinson AI, Lopez M, Rich RR, Rosenfeld SI, Rosenwasser LJ.

Ann Allergy Asthma Immunol. 1996 Mar;76(3):282-94. Erratum in: Ann Allergy Asthma Immunol 1996 Oct;77(4):262.

PMID:
8634885
47.

Tannic acid's effect on bird antigen.

Craig TJ, Hershey J, Engler RJ, Carpenter G, Smith L, Salata K.

Ann Allergy Asthma Immunol. 1995 Oct;75(4):348-50.

PMID:
7583852
48.

Cardiac arrest after intrauterine instillation of 32% dextran-70 during hysteroscopy.

Kuzma PJ, McLoughlin TM Jr, Engler RJ.

Can J Anaesth. 1995 Jun;42(6):557. No abstract available.

PMID:
7543027
49.

Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.

Engler RJ, Squire E, Benson P.

Ann Allergy Asthma Immunol. 1995 Feb;74(2):155-9.

PMID:
7697475
50.

Persistent white lesions of the tongue in a patient with low CD4 counts.

Martinez MJ Jr, Konzelman JL, Engler RJ.

Ann Allergy Asthma Immunol. 1995 Feb;74(2):134-9. No abstract available.

PMID:
7697471

Supplemental Content

Loading ...
Support Center